Michael Ackermann

Chairman, Oyster Point Pharmaceuticals, Inc.; Chairman, Tarsus Pharmaceuticals, Inc.; CEO, Presidio Medical, Inc.


John Berdahl, MD

CEO, Equinox; Ophthalmologist, Vance Thompson Vision


Ryan Bouchard

VP Medical Devices, Ora, Inc.


Janet Burk

Publisher, Retina Today


Tom Burns

President and CEO, Glaukos


Chris Calcaterra

COO, Glaukos


Steve Charles, MD

Founder, Charles Retina Institute


Andy Corley

Partner, Flying-L Partners


Vincent Deramo, MD

Co-founder, ConnectOnCall; Partner, Long Island Vitreoretinal Consultants


Bernie Haffey

Founder, Haffey & Co.


Paul Hallen

Global Head Retina & Glaucoma, Alcon


Rick Heinick

Chairman, TearClear


John Hendrick

President, SafeCo, LLC


Malik Kahook, MD

Vice-Chair Translational Research and Chief, Glaucoma Service, University of Colorado Eye Center


Ron Kurtz, MD

CEO, RxSight, Inc.


Mike Lambert, MD

Founder, Retina and Vitreous of Texas; Board Member, LVX System


James Mazzo

Global President, Ophthalmic Devices, Carl Zeiss Meditec


Zeshan Muhammedi

Co-founder, CEO, FundRx


Quinton Oswald

CEO, Notal Vision


Ram Palanki

Senior VP of Commercial Strategy and Operations, REGENXBIO


Samir Patel, MD


Ed Peterson

Global General Manager, Aviana Molecular Technologies


Jane Rady

Global General Manager, Aviana Molecular Technologies


Firas Rahhal, MD

Partner, ExSight Ventures, Sr. Partner, Retina-Vitreous Associates Medical Group


Tushar Ranchod, MD

Founder, Chairman, CTO, BroadSpot Imaging Corp.; Partner, Bay Area Retina


David Robinson

Partner, Protean, LLC


Aron Shapiro

Sr. VP and Chief Commercial Officer, Ora, Inc.


Ramin Valian

VP Retina, Surgical & Upstream Marketing, Allergan


Jeffry Weinhuff

Managing Partner, Visionary Venture Fund


Bob Zatarain

CEO, Oculus Surgical, Inc.